Rare Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have a genetic change in one of the CAMK2 genes that has been confirmed or is likely to be harmful
- You are willing to have your information recorded anonymously in a national or international database
Who may not be able to join:
- You have a genetic change in the CAMK2 gene that is classified as a "Variant of Unknown Significance" (meaning scientists are not yet sure if the change is harmful) — in these cases, additional laboratory testing would need to be done first before you could be considered
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Danielle CM Veenma, MD PhD, Erasmus Medical Center
Phone: 010-7037815
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Age of milestone achievement; Presence of seizures; Adaptive Behavior Assessment System 3 (ABAS-3) score; Social Responsiveness Scale, Second Edition (SRS-2) total score; Aberrant Behavior Checklist (ABC) score
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.